Correlation Between LABOCANNA and ALZECURE PHARMA

Can any of the company-specific risk be diversified away by investing in both LABOCANNA and ALZECURE PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LABOCANNA and ALZECURE PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between LABOCANNA SA ZY 10 and ALZECURE PHARMA AB, you can compare the effects of market volatilities on LABOCANNA and ALZECURE PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LABOCANNA with a short position of ALZECURE PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of LABOCANNA and ALZECURE PHARMA.

Diversification Opportunities for LABOCANNA and ALZECURE PHARMA

-0.43

Correlation Coefficient

LABOCANNA  ALZECURE PHARMA

Very good diversification

The 3 months correlation between LABOCANNA and ALZECURE is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding LABOCANNA SA ZY 10 and ALZECURE PHARMA AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALZECURE PHARMA AB and LABOCANNA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LABOCANNA SA ZY 10 are associated (or correlated) with ALZECURE PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALZECURE PHARMA AB has no effect on the direction of LABOCANNA i.e., LABOCANNA and ALZECURE PHARMA go up and down completely randomly.

Pair Corralation between LABOCANNA and ALZECURE PHARMA

Assuming the 90 days horizon LABOCANNA SA ZY 10 is expected to under-perform the ALZECURE PHARMA. But the stock apears to be less risky and, when comparing its historical volatility, LABOCANNA SA ZY 10 is 10.83 times less risky than ALZECURE PHARMA. The stock trades about -0.15 of its potential returns per unit of risk. The ALZECURE PHARMA AB is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  22.00  in ALZECURE PHARMA AB on April 25, 2025 and sell it today you would earn a total of  2.00  from holding ALZECURE PHARMA AB or generate 9.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

LABOCANNA SA ZY 10  vs.  ALZECURE PHARMA AB

LABOCANNA SA ZY

Risk-Adjusted Performance

Very Weak

Over the last 90 days LABOCANNA SA ZY 10 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in August 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

ALZECURE PHARMA AB

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ALZECURE PHARMA AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ALZECURE PHARMA reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with LABOCANNA and ALZECURE PHARMA

The main advantage of trading using opposite LABOCANNA and ALZECURE PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LABOCANNA position performs unexpectedly, ALZECURE PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALZECURE PHARMA will offset losses from the drop in ALZECURE PHARMA's long position.

The idea behind LABOCANNA SA ZY 10 and ALZECURE PHARMA AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.